RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases
US10570391B2 · kind B2 · utility
8Cited by
12References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2016 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Jun 21, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides RNAi agents, e.g., double stranded RNAi agents, that target the transthyretin (TTR) gene and methods of using such RNAi agents for treating or preventing TTR-associated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.